Rituximab for IgG4-related disease: A prospective, open-label trial

Annals of the Rheumatic Diseases

Volumn 74, Issue 6, 2015, Pages 1171-1177

  Carruthers, Mollie N ^a   Topazian, Mark D ^b   Khosroshahi, Arezou ^c   Witzig, Thomas E ^a   Wallace, Zachary S ^a   Hart, Philip A ^b   Deshpande, Vikram ^b   Smyrk, Thomas C ^b   Chari, Suresh ^b   Stone, John H ^a   Kvien, Tore K ^d  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b MAYO CLINIC   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G4; RITUXIMAB; ANTIRHEUMATIC AGENT; GLUCOCORTICOID; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; DISEASE ACTIVITY; DRUG EFFICACY; DRUG RESPONSE; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN G4 RELATED DISEASE; KLEBSIELLA INFECTION; LEGIONNAIRE DISEASE; MALE; MONOTHERAPY; OUTCOME ASSESSMENT; PILOT STUDY; PNEUMONIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; REMISSION; URINARY TRACT INFECTION; AGED; AUTOIMMUNE DISEASES; COHORT ANALYSIS; DRUG COMBINATION; IMMUNOLOGY; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

AGED; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTIRHEUMATIC AGENTS; AUTOIMMUNE DISEASES; COHORT STUDIES; DRUG THERAPY, COMBINATION; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; PILOT PROJECTS; PROSPECTIVE STUDIES; REMISSION INDUCTION; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84930022653     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2014-206605     Document Type: Article

References (28)

1. Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med 2012; 366:539-51.
2. Kamisawa T, Chari ST, Giday S.A., et al. Clinical profile of autoimmune pancreatitis and its histological subtypes: an international multicenter survey. Pancreas 2011; 40:809-14.
3. Carruthers MN, Stone JH, Khosroshahi A. The latest on IgG4-RD: a rapidly emerging disease. Curr Opin Rheumatol 2012; 24:60-9.
4. Mahajan VS, Mattoo H, Deshpande V., et al. IgG4-related disease. Annu Rev Pathol. 2014; 9:315-47.
5. Deshpande V, Zen Y, Chan J.K., et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol 2012; 25:1181-92.
6. Carruthers MN, Khosroshahi A, Augustin T., et al. The diagnostic utility of serum IgG4 concentrations in IgG4-related disease. Ann Rheum Dis 2015; 74:14-18.
7. Kamisawa T, Shimosegawa T, Okazaki K., et al. Standard steroid treatment for autoimmune pancreatitis. Gut 2009; 58:1504-7.
8. Tomiyama T, Uchida K, Matsushita M., et al. Comparison of steroid pulse therapy and conventional oral steroid therapy as initial treatment for autoimmune pancreatitis. J Gastroenterol 2011; 46:696-704.
9. Ghazale A, Chari ST, Zhang L, et al. Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy. Gastroenterology 2008; 134:706-15.
10. Hart PA, Topazian MD, Witzig T.E., et al. Treatment of relapsing autoimmune pancreatitis with immunomodulators and RTX: the Mayo Clinic experience. Gut 2013; 62:1607-15.
11. Sandanayake NS, Church NI, Chapman M.H., et al. Presentation and management of post-treatment relapse in autoimmune pancreatitis/immunoglobulin G4-associated cholangitis. Clin Gastroenterol Hepatol 2009; 7:1089-96.
12. Masaki Y.; for the All-Japan IgG4-Research Team. Glucocorticoids for the Treatment of IgG4-Related Disease (Abstract). 2nd international IgG4-related disease symposium, Wakiki, Hawaii, 2014.
13. Masaki Y, Shimizu H, Sato Nakamura T, et al. IgG4-related disease: diagnostic methods and therapeutic strategies in Japan. J Clin Exp Hematop 2014; 54:95-101.
14. Khosroshahi A, Bloch DB, Deshpande V, et al. RTX therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease. Arthritis Rheum 2010; 62:1755-62.
15. Khosroshahi A, Carruthers MN, Deshpande V, et al. RTX for the treatment of IgG4-related disease lessons from 10 consecutive patients. Medicine 2012; 91:57-66.
16. Maritati F, Corradi D, Versari A., et al. Rituximab therapy for chronic periaortitis. Ann Rheum Dis 2012; 71:1262-4.
17. Carruthers MN, Stone JH, Deshpande V, et al. Development of an IgG4-RD responder index. Int J Rheumatol 2012; 2012:259408.
18. Shimosegawa T, Chari ST, Frulloni L, et al. International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas 2011; 40:352-8.
19. Stone JH, Hoffman GS, Merkel P.A., et al. A disease-specific activity index for Wegener's granulomatosis: Modification of the Birmingham Vasculitis Activity Score. International Network for the Study of the Systemic Vasculitides (INSSYS). Arthritis & Rheumatism 2001; 44:912-20.
20. Stone JH, Merkel PA, Spiera R, et al. RTX versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med 2010; 363:221-32.
21. Wallace ZS, Mattoo H, Carruthers M., et al. Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations. Ann Rheum Dis 2015; 74:190-5.
22. Tabata T, Kamisawa T, Takuma K., et al. Serial changes of elevated serum IgG4 levels in IgG4-related systemic disease. Intern Med 2011; 50:69-75.
23. Ngwa TN, Law R, Murray D., et al. Serum immunoglobulin G4 level is a poor predictor of immunoglobulin G4-related disease. Pancreas 2014; 43:704-7.
24. Trotti A, Colevas AD, Setser A, et al. CTCAE v3.0: development of a comprehensive grading system for the adverse events of cancer treatment. Semin Radiat Oncol 2003; 13:176-81.
25. Hart PA, Kamisawa T, Brugge W.R., et al. Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis. Gut 2013; 62:1771-6.
26. Topazian M, Witzig TE, Smyrk T.C., et al. RTX therapy for refractory biliary strictures in immunoglobulin G4-associated cholangitis. Clin Gastroenterol Hepatol 2008; 6:364-6.
27. Mattoo H, Mahajan VS, Della-Torre E, et al. De novo oligoclonal expansions of circulating plasmablasts in active and relapsing IgG4-related disease. J Allergy Clin Immunol 2014; 134:679-87.
28. Oseini AM, Chaiteerakij R, Shire A.M., et al. Utility of serum immunoglobulin G4 in distinguishing immunoglobulin G4-associated cholangitis from cholangiocarcinoma. Hepatology 2011; 54:940-8.